Assignee
WUXI FORTUNE PHARMACEUTICAL CO LTD
CN·4 granted patents·1 citations·filing 2016–2017
Top patents by PatentIndex Score
4 records- 0164US10174056B2Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·1 cites·20 claims
- 0249US10774094B2Crystal forms and salt forms of 7h-pyrrolo[2,3-d]pyrimidine compounds and preparation method thereofWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·10 claims
- 0341US10617690B2JAK inhibitorWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 14, 2020·0 cites·27 claims
- 0436US10174036B2Substituted pyrazoles as JAK inhibitorsWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when WUXI FORTUNE PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →